Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on October 19, 2026

Oct. 19, 2026

VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity

Indeterminate GlobeNewswire

Oct. 19, 2026

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Indivior to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 19, 2026

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

Oct. 19, 2026

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Indeterminate GlobeNewswire

Oct. 19, 2026

UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC

Indeterminate GlobeNewswire

Oct. 19, 2026

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Indeterminate GlobeNewswire

Oct. 19, 2026

Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences

Indeterminate GlobeNewswire

Oct. 19, 2026

Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®

Indeterminate GlobeNewswire

Oct. 19, 2026

Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING

Indeterminate GlobeNewswire

Oct. 19, 2026

Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 19, 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

DEEP SEA MINERALS CORP. HIGHLIGHTS U.S. TREASURY RECOGNITION OF DEEP SEA MINING IN CRITICAL MINERALS POLICY AND PROVIDES CORPORATE UPDATE

Indeterminate GlobeNewswire

Oct. 19, 2026

Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD)

Indeterminate GlobeNewswire

Oct. 19, 2026

Major Drilling Announces Renewal of Normal Course Issuer Bid

Indeterminate GlobeNewswire

Oct. 19, 2026

Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM

Indeterminate GlobeNewswire

Oct. 19, 2026

Erdene Provides Q3 2026 Update and Notice of Conference Call and Webcast

Indeterminate GlobeNewswire

Oct. 19, 2026

HPQ Silicon Partners with Open Markets to Scale Its Battery Business into a Standalone Company and Pursue a Listing on a Major U.S. Exchange

Indeterminate GlobeNewswire